References
- 1. World Health Organization. Reducing risks, promoting healthy life. The World Health Report. 2002, Geneva
- 2. Ohman EM, Bhatt DL, Steg PG, et al. The Reduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic eventsstudy design. Am Heart J 2006; 151:786-796
- 3. Cinteza M, Pana B, Cochino M, et al. Prevalence and control of cardiovascular risk factors in Romania cardio-zone national study. Mædica A Journal of Clinical Medicine. 2007;2(4).
- 4. Kiely DK, Wolf PA, Cupples LA, Beiser AS, Myers RH. Familial aggregation of stroke. The Framingham Study. Stroke. 1993;24:1366-1371.
- 5. Liao D, Myers R, Hunt S, Shahar E, Paton C, et al. Familial history of stroke and stroke risk. The Family Heart Study. Stroke. 1997;28:1908-1912.
- 6. Alberts MJ. Genetic aspects of cerebrovascular disease. Stroke. 1991;22(2):276-80.
- 7. Ariyaratnam R, Casas JP, Whittaker J, et al. Genetics of ischaemic stroke among persons of non-European descent: a meta-analysis of eight genes involving approximately 32,500 individuals. PLoS Med. 2007;4(4):e131.
- 8. Matarin M, Brown WM, Dena H, et al. Candidate gene polymorphisms for ischemic stroke, Stroke. 2009;40(11):3436-42. Epub 2009 Sep 3.
- 9. Carr FJ, McBride MW, Carswell HVO, et al. Genetic Aspects of Stroke: Human and Experimental Studies. Journal of Cerebral Blood Flow & Metabolism. 2002;22:767-773.
- 10. Cvetkovic JT, Wiklund PG, Ahmed E, et al. Polymorphisms of IL-1b, IL-1Ra, and TNF-α genes: A nested case-control study of their association with risk for stroke. Journal of Stroke & Cerebrovascular Diseases. 2005;14(1):29-35.
- 11. Clark WM. Cytokines and reperfusion injury. Neurology. 1997;Suppl.4:10-4
- 12. Revilla M, Castillo J, Davalos A, Chamorro A. A-174G/C polymorphism of the interleukin 6 gene in patients with lacular infarction. Neurosci Lett. 2002;324:29-32.
- 13. Hoppe C, Klitz W, D’Harlingue K, et al. Confirmation of an association between the TNF(−308) promoter polymorphism and stroke risk in children with sickle cell anemia. Stroke. 2007;38:2241-2246.
- 14. Um JY, Lee JH, Joo JC, et al. Association between tumor necrosis factoralpha gene polymorphism and Sasang constitution in cerebral infarction. Am J Chin Med. 2005;33:547-557.
- 15. Hallenbeck JM. Cytokines, macrophages and leukocytes in brain ischemia. Neurology. 1997;24:445-451.
- 16. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-1558.
- 17. Welton NJ, Caldwell DM, Adamopoulos E, Vedhara K. Mixed treatment comparison meta-analysis of complex interventions: psychological interventions in coronary heart disease. Am J Epidemiol. 2009;169:1158-1165.
- 18. Guanglin Cui et al. Polymorphism of tumor necrosis factor alpha (TNFalpha) gene promoter, circulating TNF-alpha level, and cardiovascular risk factor for ischemic stroke. Journal of Neuroinflammation. 2012;9:235
- 19. Ishii T, Matsuse T, Teramoto S, et al. Neither IL-1beta, IL-1 receptor antagonist, nor TNF-alpha polymorphisms are associated with susceptibility to COPD. Respir Med. 2000;94(9):847-51.
- 20. Zhang LF, Yang J, Hong Z, et al. Collaborative Group of China Multicenter Study of Cardiovascular Epidemiology. Proportion of different subtypes of stroke in China. Stroke. 2003;34:2091-2096.
- 21. Dichgans M, Markus HS. Genetic association studies in stroke: methodological issues and proposed standard criteria. Stroke. 2005;36: 2027-203.
- 22. Liu T, Clark RK, McDonnell PC, et al. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke. 1994;25:1481-1488
- 23. Achrol AS, Pawlikowska L, McCulloch CE, et al. Tumor necrosis factor-α -238G > A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations. Stroke. 2006;37:231-234.
- 24. Bis JC, Heckbert SR, Smith NL, et al. Variation in inflammation-related genes and risk of incident nonfatal myocardial infarction or ischemic stroke. Atherosclerosis. 2008;198:166-173.
- 25. Banerjee I, Gupta V, Ahmed T, et al. Inflammatory system gene polymorphism and the risk of stroke: a case-control study in an Indian population. Brain Res Bull. 2008;75:158-165.
- 26. Tong Y, Geng Y, Xu J, et al. The role of functional polymorphisms of the TNF-alpha gene promoter in the risk of ischemic stroke in Chinese Han and Uyghur populations: two case-control studies. Clin. Chim. Acta. 2010;411:1291-1295.
- 27. Hoppe C, Klitz W, D’Harlingue K, et al. Confirmation of an association between the TNF(-308) promoter polymorphism and stroke risk in children with sickle cell anemia. Stroke. 2007;38:2241-2246.
- 28. Khan SA, Aslam M, Owais M, Zaheer MS. Correlation between tumour necrosis factor-alpha and other co-variates and different grades of blood pressure in essential hypertensive patients. Ind medica Biomedical Research. 2010;21(2):184-188.
- 29. Zhao Y, Xia S, Zou L. The association between polymorphism of TNF-alpha gene and hypertensive disorder complicating pregnancy. J Huazhong Univ Sci Technolog Med Sci. 2007;27(6):729-32.
- 30. Yan-yan Li. Tumor Necrosis Factor-Alpha G308α Gene Polymorphism and Essential Hypertension: A Meta-Analysis Involving 2244 Participants. PLoS ONE. 2012;7(4):e35408.